These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28342423)

  • 1. A Bioinformatics approach to designing a Zika virus vaccine.
    Dey S; Nandy A; Basak SC; Nandy P; Das S
    Comput Biol Chem; 2017 Jun; 68():143-152. PubMed ID: 28342423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools.
    Antonelli ACB; Almeida VP; de Castro FOF; Silva JM; Pfrimer IAH; Cunha-Neto E; Maranhão AQ; Brígido MM; Resende RO; Bocca AL; Fonseca SG
    Sci Rep; 2022 Jan; 12(1):53. PubMed ID: 34997041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential targets for therapeutic intervention and structure based vaccine design against Zika virus.
    Qadir A; Riaz M; Saeed M; Shahzad-Ul-Hussan S
    Eur J Med Chem; 2018 Aug; 156():444-460. PubMed ID: 30015077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of potent Zika-dengue virus antibody cross-neutralization.
    Barba-Spaeth G; Dejnirattisai W; Rouvinski A; Vaney MC; Medits I; Sharma A; Simon-Lorière E; Sakuntabhai A; Cao-Lormeau VM; Haouz A; England P; Stiasny K; Mongkolsapaya J; Heinz FX; Screaton GR; Rey FA
    Nature; 2016 Aug; 536(7614):48-53. PubMed ID: 27338953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Structural Modeling and Conserved Epitopes Prediction of Zika Virus Envelop Protein for Vaccine Development.
    Ashfaq UA; Ahmed B
    Viral Immunol; 2016 Sep; 29(7):436-43. PubMed ID: 27438351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development.
    Dikhit MR; Ansari MY; Vijaymahantesh ; Kalyani ; Mansuri R; Sahoo BR; Dehury B; Amit A; Topno RK; Sahoo GC; Ali V; Bimal S; Das P
    Infect Genet Evol; 2016 Nov; 45():187-197. PubMed ID: 27590716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and purification of domain III proteins from Dengue and Zika viruses.
    Corzo-Gómez J; García-Cordero J; Montes Gómez AE; Bernal-Siria K; Namorado-Tónix K; Gutierrez-Castañeda B; Cedillo-Barrón L
    Protein Expr Purif; 2019 Oct; 162():38-43. PubMed ID: 31112759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale analysis of B-cell epitopes of envelope: Implications for Zika vaccine and immunotherapeutic development.
    Almansour I; Alfares R; Aljofi H
    F1000Res; 2018; 7():1624. PubMed ID: 31316749
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins.
    Mirza MU; Rafique S; Ali A; Munir M; Ikram N; Manan A; Salo-Ahen OM; Idrees M
    Sci Rep; 2016 Dec; 6():37313. PubMed ID: 27934901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zika virus like particles elicit protective antibodies in mice.
    Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome.
    Shahid F; Ashfaq UA; Javaid A; Khalid H
    Infect Genet Evol; 2020 Jun; 80():104199. PubMed ID: 31962160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection.
    Kumar Pandey R; Ojha R; Mishra A; Kumar Prajapati V
    J Cell Biochem; 2018 Sep; 119(9):7631-7642. PubMed ID: 29900580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in Zika vaccines].
    Wang R; Chen H; An J
    Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):188-96. PubMed ID: 29750481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika Virus Molecular Biology and Perspectives for Vaccine Development: A Review.
    Lin HH; Huang LM; Wu SC
    J Nurs Res; 2017 Feb; 25(1):3-6. PubMed ID: 28072676
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice.
    Lecouturier V; Bernard MC; Berry C; Carayol S; Richier E; Boudet F; Heinrichs J
    Vaccine; 2019 May; 37(20):2679-2686. PubMed ID: 30967310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines in 2017: Closing in on a Zika virus vaccine.
    Diamond MS; Coyne CB
    Nat Rev Immunol; 2018 Feb; 18(2):89-90. PubMed ID: 29199280
    [No Abstract]   [Full Text] [Related]  

  • 19. Pushing Forward With Zika Vaccines.
    Kennedy RB
    EBioMedicine; 2016 Nov; 13():29-30. PubMed ID: 27751766
    [No Abstract]   [Full Text] [Related]  

  • 20. Computational Analysis of Dengue Virus Envelope Protein (E) Reveals an Epitope with Flavivirus Immunodiagnostic Potential in Peptide Microarrays.
    Bergamaschi G; Fassi EMA; Romanato A; D'Annessa I; Odinolfi MT; Brambilla D; Damin F; Chiari M; Gori A; Colombo G; Cretich M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.